Strax

Autospela

Dr. Brentjens on CD19-Targeted T Cells in CLL and ALL

2 Visningar • 07/14/23
Dela med sig
Bädda in
administrator
administrator
Prenumeranter
0

Renier J. Brentjens, MD, PhD, associate professor, chief, Cellular Therapeutics Center, Memorial Sloan-Kettering Cancer Center, discusses clinical responses in patients with chronic lymphoblastic leukemia (CLL) or acute lymphoblastic leukemia (ALL) following infusion with CD19-Targeted T Cells.

Visa mer
0 Kommentarer sort Sortera efter
Facebook-kommentarer

Strax

Autospela